Polyamine effectors are administered locally to provide protection against
the adverse side-effects of chemotherapy or radiation therapy, such as alopecia,
mucositis and dermatitis. Pharmaceutical preparations comprising one or more polyamine
effectors formulated for topical or local delivery to epithelial or mucosal cells
are disclosed. Methods of administering the pharmaceutical preparations are also disclosed.